familial hypertrophic cardiomyopathy, type 4
Jump to navigation
Jump to search
Pathology
- ventricular hypertrophy
- usually asymmetric
- often involves the interventricular septum
Genetics
- associated with defects in MYBPC3
- inter- & intrafamilial variability
Clinical manifestations
- dyspnea
- palpitations
- chest pain
- syncope
- symptoms provoked by exercise
Laboratory
Complications
Management
- investigational
- MYBPC3 gene mutation successfully repaired in human embryos using CRISPR technology[2]
More general terms
References
- ↑ OMIM https://mirror.omim.org/entry/115197
- ↑ 2.0 2.1 Ma H, Marti-Gutierrez N, Park SW et al Correction of a pathogenic gene mutation in human embryos. Nature (2017). Published online 02 August 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28783728 <Internet> http://www.nature.com/nature/journal/vaop/ncurrent/full/nature23305.html